Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Health Management and Informatics, University of Central Florida, Orlando, FL, USA.
Subst Abus. 2021;42(2):153-157. doi: 10.1080/08897077.2021.1903659. Epub 2021 Apr 2.
Buprenorphine is one of the gold standard medication treatments for opioid use disorder (OUD), with proven effectiveness in preventing overdose, increasing abstinence, and improving quality of life. In the United States, buprenorphine can be legally prescribed and administered in office-based settings from clinicians who are specially credentialed to provide that care under the X-waiver. We believe the X-waiver will ultimately be repealed, but there is a need for a variety of strategies to create a new treatment system after the X-waiver. Building a new tier of treatment capacity will require educational outreach, systems strategies, and enhanced payments.
丁丙诺啡是阿片类药物使用障碍（OUD）的黄金标准药物治疗方法之一，已被证明可有效预防过量用药、增加戒除率和提高生活质量。在美国，丁丙诺啡可由专门获得 X 豁免认证的临床医生在办公室环境中合法开具和管理，以提供这种护理。我们相信 X 豁免最终将被废除，但在 X 豁免之后，需要制定各种策略来创建一个新的治疗系统。建立新的治疗能力层级将需要教育推广、系统策略和增加支付。
